Computers in Drug Design Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

spartan software: ______ software program for analyzing _________

A

representative/ small molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

spartan software analyzes

A

atomic charges, thermodynamics, electrical, solvation and other properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

a molecular dynamics program measures ___________

A

the movement of each atom in a structure every femtosecond

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

define femtosecond

A

(1X10^-15)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

molecular dynamics predicts the ___ of each atom at ______

A

energy/ each simulated orientation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

molecular dynamics allows for ____ a molecule to _____________ to ______ and ______

A

“heating”/ introduce energy/ overcome “saddles”/ find lower energy conformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

molecular modeling describes and predicts how a compound interacts ______ and _______

A

in solution/ with its cellular target(s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

molecular modeling, compound only =

A

structural overlays

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

molecular modeling, compound and protein target =

A

molecular docking (SBDD), de novo modeling and homology modeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

True or False: molecular modeling software generates numerous potential structural overlays

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

True or False: molecular modeling software identifies the most likely correct overlay

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

molecular modeling structural overlays are most often used to

A

1) identify pharmacophore for a series of analogues 2) predict binding conformation of a new series of analogues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

molecular docking:

A

fitting a drug or potential drug into a known binding site and analyzing interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

molecular docking can predict ____ of new compounds before synthesis and evaluation

A

potential binding conformation (and biological activity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

True or False: molecular docking can be manual or automatic

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

molecular docking: rigid target and ligand:

A

simplest and quickest, you need to know the active conformation of ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

molecular docking: rigid target/ flexible ligand

A

more complex, you don’t need to know the active conformation of the ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

molecular docking: flexible target and ligand

A

very complicated, expensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the first step in molecular docking?

A

Obtaining the crystal structure - co-crystal structure is important

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

True or false: in molecular docking you identify the amino acids lining the binding site

A

true

21
Q

in molecular docking, you identify the key interactions between:

A

ligand-protein and ligand-water molecules

22
Q

in molecular docking, after docking a new compound into the binding site, you identify _________ by _________

A

potential high affinity binders/ binding energy analysis

23
Q

what do you do after you identify a new lead compound through molecular docking?

A

synthesize and test it

24
Q

how do you start de novo modeling?

A

get crystal and co-crystal structure (of ligand in binding site)

25
Q

in de novo modeling, you identify the binding site, the amino acids lining the binding site, other binding regions in the binding site, and then you

A

design and build new ligands to fit into the binding site

26
Q

you synthesize and test ________

A

low energy binders

27
Q

what can you use to get a lead compound for SBDD?

A

de novo modeling

28
Q

homology modeling:

A

create a three-dimensional model of an unknown protein based on amino acid sequence similarity with a protein of known 3D structure

29
Q

true or false: the majority of different amino acid sequences adopt a relatively small number of structures

A

true

30
Q

name two secondary structures

A

alpha helix, beta sheets

31
Q

name two tertiary structures

A

salt bridges, disulfide bonds

32
Q

___________ is used to predict potential binding sites

A

homology modeling

33
Q

__________ is used with standard modeling procedures to dock compounds in binding site

A

homology modeling

34
Q

how do you start homology modeling?

A

identify homologous proteins and determine sequence similarity

35
Q

after you find homologous proteins for homology modeling and determine sequence similarity, you _____ and identify ______ and _________ regions.

A

align the sequences/ structurally conserved/ structurally variable

36
Q

in homology modeling, you generate _____ for structurally conserved residues of the unknown structure and _________ for the structurally variable regions in the unknown structure

A

coordinates/ conformations

37
Q

after you build the side-chain conformations in homology modeling, you

A

refine and evaluate the unknown structure

38
Q

why should you not design structures that completely fill the binding pocket?

A

space for future optimization is needed, space allows for different binding conformations than predicted

39
Q

are rigid or flexible newly designed ligands preferred for molecular modeling/ docking?

A

flexible - allows for different binding conformations

40
Q

when do you add rigidity to ligands?

A

second or third iterations

41
Q

should the binding conformation of a ligand be a stable conformation?

A

yes

42
Q

define “in silico”

A

performed on a computer or via computer simulation

43
Q

docking based screening

A

virtual libraries are docked into a known receptor or enzyme binding site and scored for their potential ability to bind with high affinity

44
Q

ligand-based screening types:

A

pharmacophore models and chemical similarity

45
Q

ligand-based screening - pharmacophore models:

A

compounds known to bind in the same site on a receptor or enzyme are used to build a model of the binding site

46
Q

what is a ligand-based screening pharmacophore model used for?

A

docking-based screening

47
Q

ligand-based screening - chemical similarity:

A

lead compound is compared to structure databases to identify other molecular structures with similar pharmacophoric and physicochemical elements

48
Q

are computers utilized at all stages of drug development?

A

yes